These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SCLERAL THICKNESS IN THE FELLOW EYES OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY. Aichi T; Terao N; Imanaga N; Sawaguchi S; Wakugawa S; Miyara Y; Oshiro A; Yamauchi Y; Koizumi H Retina; 2023 Sep; 43(9):1573-1578. PubMed ID: 37262427 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography. Lee YJ; Lee YJ; Lee JY; Lee S Sci Rep; 2021 Mar; 11(1):5872. PubMed ID: 33712652 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488 [TBL] [Abstract][Full Text] [Related]
6. Biometric characteristics of eyes with central serous chorioretinopathy. Oh JH; Oh J; Togloom A; Kim SW; Huh K Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360 [TBL] [Abstract][Full Text] [Related]
7. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082 [TBL] [Abstract][Full Text] [Related]
9. Relationship Between Scleral Thickness and Choroidal Structure in Central Serous Chorioretinopathy. Imanaga N; Terao N; Sonoda S; Sawaguchi S; Yamauchi Y; Sakamoto T; Koizumi H Invest Ophthalmol Vis Sci; 2023 Jan; 64(1):16. PubMed ID: 36662534 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography. Yang J; Wang E; Yuan M; Chen Y Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy]. Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240 [TBL] [Abstract][Full Text] [Related]
12. Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography. Izumi T; Maruko I; Kawano T; Sakaihara M; Iida T Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):295-301. PubMed ID: 34410483 [TBL] [Abstract][Full Text] [Related]
13. Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy. Imanaga N; Terao N; Sawaguchi S; Tamashiro T; Wakugawa S; Yamauchi Y; Koizumi H Am J Ophthalmol; 2022 Mar; 235():197-203. PubMed ID: 34547278 [TBL] [Abstract][Full Text] [Related]
14. Widefield Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source OCT. Ishikura M; Muraoka Y; Nishigori N; Takahashi A; Miyake M; Ueda-Arakawa N; Miyata M; Ooto S; Tsujikawa A Ophthalmol Retina; 2022 Oct; 6(10):949-956. PubMed ID: 35436598 [TBL] [Abstract][Full Text] [Related]
15. Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population. Arora S; Pyare R; Sridharan P; Arora T; Thakar M; Ghosh B Indian J Ophthalmol; 2016 Oct; 64(10):747-751. PubMed ID: 27905337 [TBL] [Abstract][Full Text] [Related]
16. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography. Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721 [TBL] [Abstract][Full Text] [Related]
18. Central serous chorioretinopathy and the sclera: what we have learned so far. Koizumi H; Imanaga N; Terao N Jpn J Ophthalmol; 2024 Sep; 68(5):419-428. PubMed ID: 39150610 [TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of choroidal parameters and retinal thickness in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography: a cross-sectional study. Xiao B; Yan M; Song YP; Ye Y; Huang Z BMC Ophthalmol; 2024 Apr; 24(1):176. PubMed ID: 38632531 [TBL] [Abstract][Full Text] [Related]
20. Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy. Keidel LF; Schworm B; Langer J; Luft N; Herold T; Hagenau F; Klaas JE; Priglinger SG; Siedlecki J J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]